Tenet Health (THC)

NYSE Health Care Health Care Facilities S&P MidCap 400
$283.33
-3.13 (-1.09%)
Close of Nov 06, 2026 · end-of-day data
Next earnings date
Not scheduled yet
No report date announced in the next three weeks.
Consensus EPS estimate
—
Shown once a date is announced.
Trailing 12-month EPS
$34.47
Diluted, last four reported quarters

Earnings surprise history

reported EPS vs consensus
ReportedQuarterEPS estimateReported EPSSurprise
Oct 29, 2026Sep/2026$4.60$6.64+44.4%

Our record of THC's reports since we began tracking; it grows each quarter.

Latest results, in brief

All THC 8-K briefs →
Oct 29, 6:47 AM ET

Tenet Healthcare Q3 net income rises to $1.000 billion; raises 2026 EBITDA outlook

Positive earnings 2.02

Tenet Healthcare reported third quarter 2026 net income available to common shareholders of $1.000 billion, or $12.41 per diluted share, up from $342 million, or $3.86, a year earlier, and raised its full-year 2026 Adjusted EBITDA outlook to $5.05 billion to $5.20 billion. The quarter includes a $147 million favorable net impact from timing-related adjustments tied to the early conclusion of revenue cycle management agreements with CommonSpirit Health, which the company says do not change its full-year revenue expectations.

  • Third quarter 2026 net income available to common shareholders was $1.000 billion, or $12.41 per diluted share, versus $342 million, or $3.86, in third quarter 2025.
  • Consolidated Adjusted EBITDA rose 23.3% to $1.355 billion, and adjusted diluted EPS increased 79.5% to $6.64.
  • FY 2026 Adjusted EBITDA outlook is now $5.05 billion to $5.20 billion, a $195 million increase at the midpoint of the range.
  • Third quarter results include a $147 million favorable net impact from transition activities and timing-related adjustments under the CommonSpirit agreements.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Quarter endedRevenueYoYEPS (diluted)YoYNet incomeNet margin
Sep 2026$5.63B+6.5% $12.41+221.5% $1.00B17.8%
Jun 2026$5.63B+6.8% $9.84+213.4% $826.00M14.7%
Mar 2026$5.37B+2.8% $8.01+87.6% $702.00M13.1%
Dec 2025$5.53B+8.9% $4.21+22.7% $371.00M6.7%
Sep 2025$5.29B+3.2% $3.86-21.1% $342.00M6.5%
Jun 2025$5.27B+3.2% $3.14+18.9% $288.00M5.5%
Mar 2025$5.22B-2.7% $4.27-80.0% $406.00M7.8%
Dec 2024$5.07B-6.0% $3.43+49.1% $318.00M6.3%

From Tenet Health's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.

Annual results

Fiscal yearRevenueGrowthEPS (diluted)GrowthNet margin
FY2025$21.31B+3.1% $15.49-52.6%6.6%
FY2024$20.68B+0.5% $32.70+472.7%15.5%
FY2023$20.56B+7.2% $5.71+50.7%3.0%
FY2022$19.17B-1.6% $3.79-55.0%2.1%
FY2021$19.48B+10.5% $8.42+124.5%4.7%

Frequently asked questions

When is Tenet Health's next earnings date?

Tenet Health has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.

What did Tenet Health earn last quarter?

For the quarter ended Sep 2026, Tenet Health reported diluted EPS of $12.41 (+221.5% year over year) on revenue of $5.63B (+6.5%).

Where do these numbers come from?

Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.

Not investment advice. Figures can be restated by the company in later filings.